Total Payments
$13,902
2024 Payments
$1,690
Companies
47
Transactions
952
Medicare Patients
16,224
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$13,774 (99.1%)
Education$127.26 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,774 | 940 | 99.1% |
| Education | $127.26 | 12 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,688 | 132 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,507 | 146 | $0 (2024) |
| Amgen Inc. | $1,138 | 75 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,019 | 53 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,014 | 63 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $918.50 | 98 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $648.84 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $637.33 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $605.34 | 33 | $0 (2024) |
| Amarin Pharma Inc. | $487.10 | 37 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,690 | 117 | Novartis Pharmaceuticals Corporation ($217.16) |
| 2023 | $1,745 | 115 | E.R. Squibb & Sons, L.L.C. ($197.07) |
| 2022 | $2,401 | 149 | Actelion Pharmaceuticals US, Inc. ($324.03) |
| 2021 | $2,030 | 138 | Novartis Pharmaceuticals Corporation ($245.78) |
| 2020 | $1,321 | 82 | Janssen Pharmaceuticals, Inc ($293.66) |
| 2019 | $1,456 | 104 | Janssen Pharmaceuticals, Inc ($242.67) |
| 2018 | $1,374 | 117 | SANOFI-AVENTIS U.S. LLC ($171.52) |
| 2017 | $1,885 | 130 | Novartis Pharmaceuticals Corporation ($398.17) |
All Payment Transactions
952 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $39.95 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.87 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.87 | General |
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/24/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $37.83 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.81 | General |
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: DIABETES | ||||||
| 10/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/08/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.28 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,133 | 4,983 | $1.3M | $345,482 |
| 2022 | 25 | 3,771 | 5,929 | $1.4M | $380,078 |
| 2021 | 33 | 4,312 | 6,876 | $1.4M | $414,662 |
| 2020 | 43 | 5,008 | 7,936 | $1.8M | $499,867 |
Total Patients
16,224
Total Services
25,724
Medicare Billing
$1.6M
Procedure Codes
132
All Medicare Procedures & Services
132 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 820 | 1,623 | $398,725 | $147,532 | 37.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 170 | 170 | $221,000 | $55,310 | 25.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 246 | 250 | $275,000 | $33,361 | 12.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 182 | 363 | $90,250 | $30,626 | 33.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 108 | 429 | $38,070 | $18,424 | 48.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 158 | $20,540 | $9,499 | 46.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 535 | 797 | $47,820 | $8,300 | 17.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 71 | $17,395 | $7,013 | 40.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 129 | 132 | $30,360 | $6,882 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $15,170 | $5,817 | 38.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 33 | 33 | $33,000 | $5,308 | 16.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 112 | 112 | $35,280 | $5,257 | 14.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 351 | 523 | $13,075 | $3,237 | 24.8% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Office | 2023 | 12 | 12 | $9,205 | $2,816 | 30.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 55 | 58 | $3,770 | $1,142 | 30.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 13 | $5,954 | $1,061 | 17.8% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 31 | 31 | $9,765 | $1,056 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,435 | $952.42 | 39.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 32 | 32 | $2,560 | $514.88 | 20.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 28 | 28 | $7,980 | $451.88 | 5.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 32 | 32 | $2,400 | $340.16 | 14.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 15 | $1,275 | $270.16 | 21.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 22 | $770.00 | $183.01 | 23.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $560.00 | $127.88 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 870 | 1,758 | $395,550 | $152,548 | 38.6% |
About Dr. Andrew Win, MD
Dr. Andrew Win, MD is a Cardiovascular Disease healthcare provider based in New Bern, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710931712.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Win, MD has received a total of $13,902 in payments from pharmaceutical and medical device companies, with $1,690 received in 2024. These payments were reported across 952 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($13,774).
As a Medicare-enrolled provider, Win has provided services to 16,224 Medicare beneficiaries, totaling 25,724 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 132 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New Bern, NC
- Active Since 05/22/2006
- Last Updated 06/02/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1710931712
Products in Payments
- XARELTO (Drug) $1,677
- ENTRESTO (Drug) $1,330
- OPSUMIT (Drug) $878.49
- MULTAQ (Drug) $736.29
- ELIQUIS (Drug) $696.87
- Repatha (Biological) $627.81
- VERQUVO (Drug) $575.54
- BRILINTA (Drug) $563.60
- Corlanor (Drug) $506.64
- Vascepa (Drug) $487.10
- JARDIANCE (Drug) $401.82
- CAMZYOS (Drug) $286.33
- PRALUENT (Drug) $277.77
- LifeVest (Device) $267.19
- PRADAXA (Drug) $247.02
- Kerendia (Drug) $240.15
- Livalo (Drug) $192.23
- LEQVIO (Drug) $177.16
- Ozempic (Drug) $166.59
- INJECTAFER (Drug) $158.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Bern
Michael Casciello, M.d, M.D
Cardiovascular Disease — Payments: $13,458
Cardiovascular Disease $13,458
Christopher Hudson, Md, MD
Cardiovascular Disease — Payments: $11,327
Cardiovascular Disease $11,327
Alex Kirby, Md, MD
Cardiovascular Disease — Payments: $11,133
Cardiovascular Disease $11,133
Dr. Ryan Garbalosa, Do, DO
Cardiovascular Disease — Payments: $9,265
Cardiovascular Disease $9,265
John Williams, Md, MD
Cardiovascular Disease — Payments: $7,599
Cardiovascular Disease $7,599
Dr. Matthew Levine, M.d, M.D
Cardiovascular Disease — Payments: $7,406
Cardiovascular Disease $7,406